Processing

Please wait...

Settings

Settings

1. WO2015106108 - NOVEL FUNCTIONALIZED 1,3-BENZENE DIOLS AND THEIR METHOD OF USE FOR THE TREATMENT OF HEPATIC ENCEPHALOPATHY

Publication Number WO/2015/106108
Publication Date 16.07.2015
International Application No. PCT/US2015/010827
International Filing Date 09.01.2015
IPC
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
045
Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
05
Phenols
A61K 31/05 (2006.01)
CPC
A61K 31/397
A61K 31/4192
C07B 2200/05
C07B 59/002
C07D 205/04
C07D 205/06
Applicants
  • KANNALIFE, INC. [US/US]; 363 West Hills Road West Hills, New York 11743, US
Inventors
  • BRENNEMAN, Douglas E.; US
  • MCDONNELL, Mark; US
  • KINNEY, William Alvin; US
  • PETKANAS, Dean; US
Agents
  • TENER, David M.; US
Priority Data
61/926,86913.01.2014US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) NOVEL FUNCTIONALIZED 1,3-BENZENE DIOLS AND THEIR METHOD OF USE FOR THE TREATMENT OF HEPATIC ENCEPHALOPATHY
(FR) NOUVEAUX 1,3-BENZÈNE DIOLS FONCTIONNALISÉS ET LEUR PROCÉDÉ D'UTILISATION POUR LE TRAITEMENT DE L'ENCÉPHALOPATHIE HÉPATIQUE
Abstract
(EN)
Pharmaceutical compositions of the invention include novel functionalized 1,3-benzenediols having a disease-modifying action in the treatment of hepatic encephalopathy and related conditions. Pharmaceutical compositions of the invention further include novel neuroprotective agents.
(FR)
Les compositions pharmaceutiques selon l'invention comprennent de nouveaux 1,3-benzène diols fonctionnalisés ayant une action de modification de maladie dans le traitement de l'encéphalopathie hépatique et des troubles associés. Les compositions pharmaceutiques de l'invention comprennent en outre de nouveaux agents neuroprotecteurs.
Latest bibliographic data on file with the International Bureau